-
19188-5An orally available, semi-synthetic penicillin antibiotic.
-
19188-50An orally available, semi-synthetic penicillin antibiotic.
-
710000-100Cayman&rsquos AMP+ Mass Spectrometry Kit contains a positively charged reagent (AMP+) that can be coupled quantitatively to free carboxylic acids through an amide bond linkage. The resulting derivatized product thus contains a positively charged
-
710000-15Cayman&rsquos AMP+ Mass Spectrometry Kit contains a positively charged reagent (AMP+) that can be coupled quantitatively to free carboxylic acids through an amide bond linkage. The resulting derivatized product thus contains a positively charged
-
710000-50Cayman&rsquos AMP+ Mass Spectrometry Kit contains a positively charged reagent (AMP+) that can be coupled quantitatively to free carboxylic acids through an amide bond linkage. The resulting derivatized product thus contains a positively charged
-
10010332-1A hydrophobic derivative of deoxynojirimycin that potently inhibits &beta-glucosidase 2 (IC50 = 0.3 nM), less potently antagonizes glucosylceramide synthase (IC50 = 25 nM), but only poorly inhibits other GCase isoforms suppresses hapten-induced
-
10010332-10A hydrophobic derivative of deoxynojirimycin that potently inhibits &beta-glucosidase 2 (IC50 = 0.3 nM), less potently antagonizes glucosylceramide synthase (IC50 = 25 nM), but only poorly inhibits other GCase isoforms suppresses hapten-induced
-
10010332-5A hydrophobic derivative of deoxynojirimycin that potently inhibits &beta-glucosidase 2 (IC50 = 0.3 nM), less potently antagonizes glucosylceramide synthase (IC50 = 25 nM), but only poorly inhibits other GCase isoforms suppresses hapten-induced
-
10010332-500A hydrophobic derivative of deoxynojirimycin that potently inhibits &beta-glucosidase 2 (IC50 = 0.3 nM), less potently antagonizes glucosylceramide synthase (IC50 = 25 nM), but only poorly inhibits other GCase isoforms suppresses hapten-induced
-
A5326-25 mg
Thomas Scientific
AMPA positive allosteric modulator and agonist at dopamine D2 receptors, 5-HT2A receptors, and nAChRs. It decreases anxiety-like behaviors and improves cognitive deficits associated with stroke and Alzheimer’s disease. (C08-0488-514)
Price: $143.60List Price: $159.56Aniracetam is a nootropic ampakine that exhibits anxiolytic and neuroprotective activities. Aniracetam acts as a positive allosteric modulator of AMPA receptors, slowing receptor deactivation it also acts on D2 receptors, 5-HT2A receptors, and -
A5326-100 mg
Thomas Scientific
AMPA positive allosteric modulator and agonist at dopamine D2 receptors, 5-HT2A receptors, and nAChRs. It decreases anxiety-like behaviors and improves cognitive deficits associated with stroke and Alzheimer’s disease. (C08-0488-915)
Price: $288.58List Price: $320.65Aniracetam is a nootropic ampakine that exhibits anxiolytic and neuroprotective activities. Aniracetam acts as a positive allosteric modulator of AMPA receptors, slowing receptor deactivation it also acts on D2 receptors, 5-HT2A receptors, and -
A5326-500 mg
Thomas Scientific
AMPA positive allosteric modulator and agonist at dopamine D2 receptors, 5-HT2A receptors, and nAChRs. It decreases anxiety-like behaviors and improves cognitive deficits associated with stroke and Alzheimer’s disease. (C08-0489-555)
Price: $690.90List Price: $767.67Aniracetam is a nootropic ampakine that exhibits anxiolytic and neuroprotective activities. Aniracetam acts as a positive allosteric modulator of AMPA receptors, slowing receptor deactivation it also acts on D2 receptors, 5-HT2A receptors, and